- Home
- NVAX vs GB Comparison
NVAX vs GB Comparison
Compare NVAX & GB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- GB
- Stock Information
- Founded
- NVAX 1987
- GB 1980
- Country
- NVAX United States
- GB Switzerland
- Employees
- NVAX N/A
- GB N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- GB EDP Services
- Sector
- NVAX Health Care
- GB Technology
- Exchange
- NVAX Nasdaq
- GB Nasdaq
- Market Cap
- NVAX 1.3B
- GB 1.5B
- IPO Year
- NVAX 1995
- GB N/A
- Fundamental
- Price
- NVAX $8.17
- GB $7.34
- Analyst Decision
- NVAX Buy
- GB Buy
- Analyst Count
- NVAX 6
- GB 1
- Target Price
- NVAX $17.83
- GB $6.00
- AVG Volume (30 Days)
- NVAX 4.7M
- GB 1.8M
- Earning Date
- NVAX 05-09-2025
- GB 02-26-2025
- Dividend Yield
- NVAX N/A
- GB N/A
- EPS Growth
- NVAX N/A
- GB 192.38
- EPS
- NVAX N/A
- GB 0.27
- Revenue
- NVAX $682,162,000.00
- GB $503,508,645.00
- Revenue This Year
- NVAX N/A
- GB $21.30
- Revenue Next Year
- NVAX $15.02
- GB $14.08
- P/E Ratio
- NVAX N/A
- GB $26.99
- Revenue Growth
- NVAX N/A
- GB 20.43
- 52 Week Low
- NVAX $3.81
- GB $4.29
- 52 Week High
- NVAX $23.86
- GB $8.00
- Technical
- Relative Strength Index (RSI)
- NVAX 51.30
- GB 57.30
- Support Level
- NVAX $7.66
- GB $7.32
- Resistance Level
- NVAX $8.48
- GB $7.43
- Average True Range (ATR)
- NVAX 0.64
- GB 0.07
- MACD
- NVAX 0.08
- GB 0.00
- Stochastic Oscillator
- NVAX 71.43
- GB 14.52
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About GB Global Blue Group Holding AG
Global Blue Group Holding AG offers a seamless shopping and payment journey for tourists and also provides a wide range of Added-Value Payment Solutions for all the stakeholders involved, including retailers and international shoppers. The company connect thousands of retailers, acquirers, and hotels with nearly 80 million consumers across more than 50 countries, in three industries: Tax Free Shopping, Payments and Post-Purchase solutions.